Drug Approval | September 18, 2021
Zydus Cadila receives final nod for anti-depressant
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
_256_384.jpg)
CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report
It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
The amalgamation is expected to bring in a lot of synergies in terms of operational efficiency and productivity for the combined entity
Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor
The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
Research collaboration covers multiple antibody research programs
The institute will provide the world’s first unique and comprehensive capability to predict, prevent, respond and to recover from future pandemics
The platform revolutionizes how providers deliver financial services by radically simplifying the patient financial experience
Subscribe To Our Newsletter & Stay Updated
